Madhya Pradesh: Stay on Maharashtra government notification continues, supply of medical oxygen to the state remains unaffected

12:51 AM Jun 09, 2021 | Staff Reporter

Indore: The supply of medical oxygen from Maharashtra will continue uninterrupted to Madhya Pradesh as a stay by Indore bench of Madhya Pradesh High Court remains on the notification banning the supply by the neighbouring state.

Maharashtra government had banned the supply of oxygen to other states, including MP on March 30. On a petition, the court had stayed the notification and sought the Maharashtra government's explanation on it. The Maharashtra government did not reply to the notice.


On Tuesday, the court granted Maharashtra government two months to file its reply.


Previously, on September 7 also, the Maharashtra government had issued a notification banning the supply of medical oxygen to MP. The Maharashtra government had said that a large number of infected patients are being found in Maharashtra. “When their own oxygen demand is not being met, then how can we give oxygen to the patients of other states,” the notification had said.

Also Read: Indore: No entry at Choithram Mandi without vaccination, three-day vaccination drive to start

At that time also petition was move in the court on whose orders supply of oxygen supply to MP continued.

When the second wave of Covid-19 came, the Maharashtra government again stopped the supply of medical oxygen to MP by issuing a new notification in March.

Additional advocate general Pushyamitra Bhargava said that Maharashtra government was supposed to file reply by Tuesday but it did not.

The court while continuing the stay on the notification gave two months to the Maharashtra government to respond.

The next hearing has been fixed in the first week of August.

Also Read: Bhopal: Chief minister Shivraj Singh hails Modi's decision on free Covid vaccines to states as historic

(To view our epaper please Read Now. For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)